These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
7. Laparoscopic management of early-stage malignant nonepithelial ovarian tumors: surgical and survival outcomes. Shim SH; Kim DY; Lee SW; Park JY; Kim JH; Kim YM; Kim YT; Nam JH Int J Gynecol Cancer; 2013 Feb; 23(2):249-55. PubMed ID: 23318909 [TBL] [Abstract][Full Text] [Related]
8. Trends in the surgical management of malignant ovarian germcell tumors. Nasioudis D; Mastroyannis SA; Latif NA; Ko EM Gynecol Oncol; 2020 Apr; 157(1):89-93. PubMed ID: 32008791 [TBL] [Abstract][Full Text] [Related]
9. Outcome and risk factors for recurrence in malignant ovarian germ cell tumors: a MITO-9 retrospective study. Mangili G; Sigismondi C; Gadducci A; Cormio G; Scollo P; Tateo S; Ferrandina G; Greggi S; Candiani M; Lorusso D Int J Gynecol Cancer; 2011 Nov; 21(8):1414-21. PubMed ID: 21795985 [TBL] [Abstract][Full Text] [Related]
10. Long-term oncological and reproductive outcomes of fertility-sparing cytoreductive surgery in females aged 25 years and younger with malignant ovarian germ cell tumors. Ertas IE; Taskin S; Goklu R; Bilgin M; Goc G; Yildirim Y; Ortac F J Obstet Gynaecol Res; 2014 Mar; 40(3):797-805. PubMed ID: 24320102 [TBL] [Abstract][Full Text] [Related]
11. Analysis of outcomes and prognostic factors after fertility-sparing surgery in malignant ovarian germ cell tumors. Park JY; Kim DY; Suh DS; Kim JH; Kim YM; Kim YT; Nam JH Gynecol Oncol; 2017 Jun; 145(3):513-518. PubMed ID: 28372870 [TBL] [Abstract][Full Text] [Related]
13. An Analysis of Prognostic Factors in Patients with Ovarian Malignant Germ Cell Tumors Who Are Treated with Fertility-Preserving Surgery. Yang ZJ; Liu ZC; Wei RJ; Li L Gynecol Obstet Invest; 2016; 81(1):1-9. PubMed ID: 25967958 [TBL] [Abstract][Full Text] [Related]
15. [Treatment of non-testicular germ cell tumors in children and adolescents with BEP and VIP: initial results of the MAKEI 89 therapy study]. Göbel U; Bamberg M; Engert J; Gnekow AK; Haas HJ; Jürgens H; Kühl J; Lenard HG; Lumenta C; Niethammer D Klin Padiatr; 1991; 203(4):236-45. PubMed ID: 1719267 [TBL] [Abstract][Full Text] [Related]
16. Ovarian germ cell tumors in children: a 20-year retrospective study in a single institution. Yang C; Wang S; Li CC; Zhang J; Kong XR; Ouyang J Eur J Gynaecol Oncol; 2011; 32(3):289-92. PubMed ID: 21797119 [TBL] [Abstract][Full Text] [Related]
17. Clinical management of malignant ovarian germ cell tumors: A 26-year experience in a tertiary care institution. Hu T; Fang Y; Sun Q; Zhao H; Ma D; Zhu T; Wang C Surg Oncol; 2019 Dec; 31():8-13. PubMed ID: 31446304 [TBL] [Abstract][Full Text] [Related]
18. Age-dependent difference in impact of fertility preserving surgery on disease-specific survival in women with stage I borderline ovarian tumors. Sun H; Chen X; Zhu T; Liu N; Yu A; Wang S J Ovarian Res; 2018 Jun; 11(1):54. PubMed ID: 29958541 [TBL] [Abstract][Full Text] [Related]
19. Treatment of malignant ovarian germ cell tumors and preservation of fertility. Zhang R; Sun YC; Zhang GY; Wu LY; Zuo J Eur J Gynaecol Oncol; 2012; 33(5):489-92. PubMed ID: 23185794 [TBL] [Abstract][Full Text] [Related]
20. Incidence and survival rates for female malignant germ cell tumors. Smith HO; Berwick M; Verschraegen CF; Wiggins C; Lansing L; Muller CY; Qualls CR Obstet Gynecol; 2006 May; 107(5):1075-85. PubMed ID: 16648414 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]